Overview

A Study of A-101 Solution in Subjects With Common Warts.

Status:
Completed
Trial end date:
2016-09-16
Target enrollment:
Participant gender:
Summary
This is a randomized, double-blind, vehicle-controlled, parallel-group study with 3 treatment groups.
Phase:
Phase 2
Details
Lead Sponsor:
Aclaris Therapeutics, Inc.
Treatments:
Pharmaceutical Solutions